IROC Rhode Island (QARC) Publications

 
IROC Rhode Island (QARC) is a research program within the Department of Radiation Oncology that provides quality assurance and data management services for diagnostic imaging and radiation therapy in the NCI's National Clinical Trials Network (NCTN). This collection showcases journal articles and other publications written by QARC researchers.

Follow


Publications from 2017

Link

Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205), Madhur K. Garg, Fengmin Zhao, Joseph A. Sparano, Joel Palefsky, Richard Whittington, Edith P. Mitchell, Mary F. Mulcahy, Karin I. Armstrong, Nassim H. Nabbout, Shalom Kalnicki, Bassel F. El-Rayes, Adedayo A. Onitilo, Daniel J. Moriarty, Thomas J. FitzGerald, and Al B. Benson 3rd

Link

Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee, Howard M. Katzenstein, Wayne L. Furman, Marcio H. Malogolowkin, Mark D. Krailo, M. Beth McCarville, Alexander J. Towbin, Greg M. Tiao, Milton J. Finegold, Sarangarajan Ranganathan, Stephen P. Dunn, Max R. Langham, Eugene D. McGahren, Carlos Rodriguez-Galindo, and Rebecka L. Meyers

PDF

Effect of Standard Radiotherapy With Cisplatin vs Accelerated Radiotherapy With Panitumumab in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma: A Randomized Clinical Trial, Lillian L. Siu and Thomas J. FitzGerald

Link

Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial, Joseph A. Sparano, Jeannette Y. Lee, Joel Palefsky, David H. Henry, William Wachsman, Lakshmi Rajdev, David Aboulafia, Lee Ratner, Thomas J. FitzGerald, Lisa Kachnic, and Ronald Mitsuyasu

Publications from 2016

Link

Imaging and Data Acquisition in Clinical Trials for Radiation Therapy, Thomas J. FitzGerald, Maryann Bishop-Jodoin, David S. Followill, James Galvin, Michael V. Knopp, Jeff M. Michalski, Mark A. Rosen, Jeffrey D. Bradley, Lalitha K. Shankar, Frances Laurie, M. Giulia Cicchetti, Janaki Moni, C. Norman Coleman, James A. Deye, Jacek Capala, and Bhadrasain Vikram

Link

Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group, Debra L. Friedman, Mark Krailo, Doojduen Villaluna, Dan Gombos, Bryan Langholz, Rima Jubran, Carol Shields, Linn Murphree, Joan O'Brien, Sandra Kessel, Carlos Rodriguez-Galindo, Murali Chintagumpala, and Anna T. Meadows

Link

A Comparative Evaluation of Normal Tissue Doses for Patients Receiving Radiation Therapy for Hodgkin Lymphoma on the Childhood Cancer Survivor Study and Recent Children's Oncology Group Trials, Rachel Zhou, Angela Ng, Louis S. Constine, Marilyn Stovall, Gregory T. Armstrong, Joseph P. Neglia, Debra L. Friedman, Kara Kelly, Thomas J. FitzGerald, and David C. Hodgson

Publications from 2015

Link

Radiotherapy quality assurance report from children's oncology group AHOD0031, Kavita V. Dharmarajan, Debra L. Friedman, Thomas J. FitzGerald, Kathleen M. McCarten, Louis S. Constine, Lu Chen, Sandy K. Kessel, Matthew Iandoli, Fran Laurie, Cindy L. Schwartz, and Suzanne L. Wolden

Link

Patterns of relapse from a phase 3 Study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): a report from the Children's Oncology Group, Kavita V. Dharmarajan, Debra L. Friedman, Cindy L. Schwartz, Lu Chen, Thomas J. FitzGerald, Kathleen M. McCarten, Sandy K. Kessel, Matthew Iandoli, Louis S. Constine, and Suzanne L. Wolden

Link

A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group study, Terzah M. Horton, Richard A. Drachtman, Lu Chen, Peter D. Cole, Kathleen McCarten, Stephan Voss, Robert P. Guillerman, Allen Buxton, Scott C. Howard, Shirley M. Hogan, Andrea M. Sheehan, Dolores Lopez-Terrada, Matthew D. Mrazek, Neeraj Agrawal, Meng-Fen Wu, Hao Liu, Pedro A. De Alarcon, Tanya M. Trippet, and Cindy L. Schwartz

Link

A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor-risk stage III non-small-cell lung cancer: results of CALGB 30605 (Alliance)/RTOG 0972 (NRG), Rogerio Lilenbaum, Michael Samuels, Xiaofei Wang, Feng Ming Kong, Pasi A. Janne, Gregory Masters, Sreedhar Katragadda, Lydia Hodgson, Jeffrey Bogart, Jeffrey Bradley, and Everett Vokes

Link

Comparison of diagnostic performance of CT and MRI for abdominal staging of pediatric renal tumors: a report from the Children's Oncology Group, Sabah Servaes, Geetika Khanna, Arlene Naranjo, James I. Geller, Peter F. Ehrlich, Kenneth W. Gow, Elizabeth J. Perlman, Jeffrey S. Dome, Eric Gratias, and Elizabeth A. Mullen

Link

Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: a children's oncology group report, Tanya M. Trippett, Cindy L. Schwartz, R. Paul Guillerman, Alan S. Gamis, Sharon Gardner, Shirley Hogan, Wendy B. London, Lu Chen, and Pedro de Alarcon

Link

A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533, Antoinette J. Wozniak, James Moon, Charles R. Thomas Jr., Karen Kelly, Philip C. Mack, Laurie E. Gaspar, David Raben, Thomas J. Fitzgerald, Kishan J. Pandya, and David R. Gandara

Publications from 2014

Link

Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer, Hiran C. Fernando, Rodney J. Landreneau, Sumithra J. Mandrekar, Francis C. Nichols, Shauna L. Hillman, Dwight E. Heron, Bryan F. Meyers, Thomas A. DiPetrillo, David R. Jones, Sandra L. Starnes, Angelina D. Tan, Benedict D. Daly T, and Joe B. Putnam Jr

Link

A new model for imaging and radiation therapy quality assurance in the National Clinical Trials Network of the National Cancer Institute, Thomas J. Fitzgerald

Link

Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031, Debra L. Friedman, Lu Chen, Suzanne Wolden, Allen Buxton, Kathleen McCarten, Thomas J. FitzGerald, Sandra Kessel, Pedro A. De Alarcon, Allen R. Chen, Nathan Kobrinsky, Peter Ehrlich, Robert E. Hutchison, Louis S. Constine, and Cindy L. Schwartz

Link

Radiation field design in the ACOSOG Z0011 (Alliance) Trial, Reshma Jagsi, Manjeet Chadha, Janaki Moni, Karla Ballman, Fran Laurie, Thomas A. Buchholz, Armando Giuliano, and Bruce G. Haffty

Link

Trimodality therapy for superior sulcus non-small cell lung cancer: Southwest Oncology Group-Intergroup Trial S0220, Kemp H. Kernstine, James Moon, Michael J. Kraut, Katherine M. Pisters W, Joshua R. Sonett, Valerie W. Rusch, Charles R. Thomas Jr, Thomas K. Waddell, James R. Jett, Alan P. Lyss, Steven M. Keller, and David R. Gandara

Link

Radiation therapy quality assurance in clinical trials--Global Harmonisation Group, Christos Melidis and Kenneth Ulin

PDF

The impact of protocol assignment for older adolescents with Hodgkin lymphoma, Richard S. Pieters, Henry Wagner, Stephen P. Baker, Karen Morano, Kenneth Ulin, Maria Giulia Cicchetti, Maryann Bishop-Jodoin, and Thomas J. Fitzgerald

Link

Radiation therapy digital data submission process for national clinical trials network, Jialu Yu, William Straube, Charles Mayo, Tawfik Giaddui, Walter Bosch, Kenneth Ulin, Stephen F. Kry, James Galvin, and Ying Xiao

Link

New information prompts old question: is sentinel lymph node sampling equivalent to axillary lymph node dissection, Richard Cedric Zellars

Publications from 2013

Link

Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial, Judy C. Boughey, Kelly K. Hunt, and Alliance for Clinical Trials in Oncology

PDF

A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung Cancer, Yuhchyau Chen, James Moon, Kishan J. Pandya, Derick H. Lau M, Karen Kelly, Fred R. Hirsch, Laurie E. Gaspar, Mary Redman, and David R. Gandara

Link

Children's Oncology Group's 2013 blueprint for research: renal tumors, Jeffrey S. Dome, Conrad V. Fernandez, Elizabeth A. Mullen, John A. Kalapurakal, James I. Geller, Vicki Huff, Eric J. Gratias, David B. Dix, Peter F. Ehrlich, Geetika Khanna, Marcio H. Malogolowkin, James R. Anderson, Arlene Naranjo, and Elizabeth J. Perlman

Link

Does quality of radiation therapy predict outcomes of multicenter cooperative group trials? A literature review, Alysa Fairchild, William Straube, Fran Laurie, and David S. Followill

Link

Image based feasibility of renal sparing surgery for very low risk unilateral Wilms tumors: a report from the Children's Oncology Group, F. A. Ferrer, N. Rosen, K. Herbst, C. V. Fernandez, G. Khanna, J. S. Dome, E. Mullen, K. W. Gow, D. C. Barnhart, R. C. Shamberger, M. Ritchey, and P. Ehrlich

PDF

Future vision for the quality assurance of oncology clinical trials, Thomas J. Fitzgerald, Maryann Bishop-Jodoin, Walter R. Bosch, Walter J. Curran, David S. Followill, James M. Galvin, Richard Hanusik, Steven R. King, Michael V. Knopp, Fran Laurie, Elizabeth O'Mear, Jeff M. Michalski, Joel H. Saltz, Mitchell D. Schnall, Lawrence Schwartz, Kenneth Ulin, Ying Xiao, and Marcia Urie

Link

Primary nephrectomy and intraoperative tumor spill: report from the Children's Oncology Group (COG) renal tumors committee, Kenneth W. Gow

Link

Detection of preoperative wilms tumor rupture with CT: a report from the Children's Oncology Group, Geetika Khanna, Arlene Naranjo, Fredric Hoffer, Elizabeth Mullen, James Geller, Eric J. Gratias, Peter F. Ehrlich, Elizabeth J. Perlman, Nancy Rosen, Paul Grundy, and Jeffrey S. Dome

Link

Outcome of patients with localized orbital sarcoma who relapsed following treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-III and -IV, 1984-1997: a report from the Children's Oncology Group, R. Beverly Raney, Winston W. Huh, Douglas S. Hawkins, Andrea Hayes-Jordan, Lynn Million, David Rodeberg, Lisa Teot, and James Anderson

Link

Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children's Oncology Group (COG) phase II study, Stephen X. Skapek, James R. Anderson, D. Ashley Hill, David Henry, Sheri L. Spunt, William Meyer, Simon Kao, Fredric A. Hoffer, Holcombe E. Grier, Douglas S. Hawkins, and R. Beverly Raney

Link

The effect of radiation timing on patients with high-risk features of parameningeal rhabdomyosarcoma: an analysis of IRS-IV and D9803, Aaron C. Spalding, Douglas S. Hawkins, Sarah S. Donaldson, James R. Anderson, Elizabeth R. Lyden, Fran Laurie, Suzanne Wolden, Carola Arndt, and Jeff M. Michalski

Link

Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group, Gregory A. Yanik, Marguerite T. Parisi, Barry L. Shulkin, Arlene Naranjo, Susan G. Kreissman, Wendy B. London, Judith G. Villablanca, John M. Maris, Julie R. Park, Susan L. Cohn, Patrick McGrady, and Katherine K. Matthay

Publications from 2012

Link

Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance, Justin E. Bekelman, James Deye, Bhadrasain Vikram, Soren M. Bentzen, Deborah Bruner, Walter J. Curran, James Dignam, Jason A. Efstathiou, Thomas J. Fitzgerald, Coen Hurkmans, Geoffrey S. Ibbott, J. Jack Lee, Thomas E. Merchant, Jeff M. Michalski, Jatinder R. Palta, Richard Simon, Randal K. Ten Haken, Robert Timmerman, Sean Tunis, C. Norman Coleman, and James Purdy

Link

Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study, John C. Breneman, Jane L. Meza, Sarah S. Donaldson, R. Beverly Raney, Suzanne Wolden, Jeff M. Michalski, Fran Laurie, David A. Rodeberg, William Meyer, David Walterhouse, and Douglas S Hawkins

PDF

Radiation therapy quality in CCG/POG intergroup 9961: implications for craniospinal irradiation and the posterior fossa boost in future medulloblastoma trials, Bernadine Donahue, Mary A. H. Marymont, Sandra Kessel, Matthew Iandoli, Thomas J. FitzGerald, Emiko Holmes, Mehmet Kocak, James M. Boyett, Amar Gajjar, and Roger J. Packer

Link

What we have learned: the impact of quality from a clinical trials perspective, Thomas J. Fitzgerald

Link

Credentialing for participation in clinical trials, David S. Followill, Marcia Urie, James M. Galvin, Kenneth Ulin, Ying Xiao, and Thomas J. Fitzgerald

Link

Randomized phase III study of thoracic radiation in combination with paclitaxel and carboplatin with or without thalidomide in patients with stage III non-small-cell lung cancer: the ECOG 3598 study, Tien Hoang, Suzanne E. Dahlberg, Joan H Schiller, Minesh P. Mehta, Thomas J. Fitzgerald, Steven A. Belinsky, and David H. Johnson

Link

Evaluation of diagnostic performance of CT for detection of tumor thrombus in children with Wilms tumor: a report from the Children's Oncology Group, Geetika Khanna, Nancy Rosen, James R. Anderson, Peter F. Ehrlich, Jeffrey S. Dome, Kenneth W. Gow, Elizabeth Perlman, Douglas Barnhart, Kathryn Karolczuk, and Paul Grundy

Link

Effect of radiotherapy techniques (IMRT vs. 3D-CRT) on outcome in patients with intermediate-risk rhabdomyosarcoma enrolled in COG D9803--a report from the Children's Oncology Group, Chi Lin, Sarah S. Donaldson, Jane L. Meza, James R. Anderson, Elizabeth R. Lyden, Christopher K. Brown, Karen Morano, Fran Laurie, Carola A. Arndt, Charles A. Enke, and John C. Breneman

Link

Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group, Cameron K. Tebbi, Nancy P. Mendenhall, Wendy B. London, Jonathan L. Williams, Robert E. Hutchison, Thomas J. Fitzgerald, Pedro A. de Alarcon, Cindy Schwartz, and Allen R. Chauvenet

Link

Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group, Stephan D. Voss, Lu Chen, Louis S. Constine, Allen R. Chauvenet, T. J. Fitzgerald, Cindy L. Schwartz, Sue C. Kaste, and Thomas Slovis

Publications from 2011

Link

Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study, Hiran C. Fernando, Rodney J. Landreneau, Sumithra J. Mandrekar, Shauna L. Hillman, Francis C. Nichols, Bryan Meyers, Thomas A. DiPetrillo, Dwight E. Heron, David R. Jones, Benedict D. Daly T, Sandra L. Starnes, Angelina Tan, and Joe B. Putnam

Link

The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: preliminary results from the American College of Surgeons Oncology Group Z4032 trial, Hiran C. Fernando, Rodney J. Landreneau, Sumithra J. Mandrekar, Shauna L. Hillman, Francis C. Nichols, Bryan Meyers, Thomas A. DiPetrillo, Dwight Heron, David R. Jones, Benedict D. Daly T, Sandra L. Starnes, Jeffrey E. Hatter, and Joe B. Putnam

Link

S0356: a phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma, Lawrence P. Leichman, Bryan H. Goldman, Pierre O. Bohanes, Heinz J. Lenz, Charles R. Thomas, Kevin G. Billingsley, Christopher L. Corless, Syma Iqbal, Philip J. Gold, Jacqueline K. Benedetti, Kathleen D. Danenberg, and Charles D. Blanke

Link

Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: a report from the Children's Oncology Group, Lynn Million, James Anderson, John Breneman, Douglas S. Hawkins, Fran Laurie, Jeff Michalski, David Rodeberg, Moody Wharam, Suzanne Wolden, Sarah S. Donaldson, and Soft Tissue Sarcoma Committee of the Children's Oncology Group

Link

Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group, R. Beverly Raney, David O. Walterhouse, Jane L. Meza, Richard J. Andrassy, John C. Breneman, William M. Crist, Harold M. Maurer, William H. Meyer, David M. Parham, and James R. Anderson

Link

Pulmonary toxicity in Stage III non-small cell lung cancer patients treated with high-dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: a secondary analysis of Cancer and Leukemia Group B (CALGB) trial 30105, Joseph K. Salama, Thomas E. Stinchcombe, Lin Gu, Xiaofei Wang, Karen Morano, Jeffrey A. Bogart, Jeffrey C. Crawford, Mark A. Socinski, A. William Blackstock, and Everett E. Vokes

Publications from 2010

Link

Optimal equations for describing the relationship between prostate volume, number of sources, and total activity in permanent prostate brachytherapy, Jesse N. Aronowitz, Jeff M. Michalski, Gregory S. Merrick, John E. Sylvester, Juanita M. Crook, Wayne M. Butler, Christie Mawson, David Pratt, Devi Naidoo, and Kathryn Karolczuk

Link

Quality of radiotherapy reporting in randomized controlled trials of Hodgkin's lymphoma and non-Hodgkin's lymphoma: in regard to Bekelman and Yahalom (Int J Radiat Oncol Biol Phys 2009;73:492-498), Thomas J. Fitzgerald, Maria Giulia Cicchetti, Richard Hanusik, Sandy Kessel, Frances Laurie, Kathleen M. McCarten, Janaki Moni, Nancy Rosen, Allen R. Chauvenet, Louis S. Constine, James Deye, Bhadrasain Vikram, Debra Friedman, Robert B. Marcus Jr., Nancy P. Mendenhall, Jon L. Williams, James Purdy, Joel Saltz, Cindy L Schwartz, Keith S. White, Suzanne Wolden, Kenneth Ulin, Marcia Urie, Richard S. Pieters, and Maryann Bishop-Jodoin

Link

Impact of high-dose chemotherapy on the ability to deliver subsequent local-regional radiotherapy for breast cancer: analysis of Cancer and Leukemia Group B Protocol 9082, Lawrence B. Marks, Constance Cirrincione, Thomas J. Fitzgerald, Fran Laurie, Arvin S. Glicksman, James Vredenburgh, Leonard R Prosnitz, Elizabeth J. Shpall, Michael Crump, Paul G. Richardson, Michael W. Schuster, Jinli Ma, Bercedis L. Peterson, Larry Norton, Steven Seagren, I. Craig Henderson, David D. Hurd, and William P. Peters

Link

Impact of tumor viability at second-look procedures performed before completing treatment on the Intergroup Rhabdomyosarcoma Study Group protocol IRS-IV, 1991-1997: a report from the children's oncology group, Beverly Raney, Julie Stoner, James Anderson, Richard Andrassy, Carola Arndt, Ken Brown, William Crist, Harold Maurer, Stephen Qualman, Moody Wharam, Eugene Wiener, William Meyer, and Andrea Hayes-Jordan

Link

Treatment results for patients with localized, completely resected (Group I) alveolar rhabdomyosarcoma on Intergroup Rhabdomyosarcoma Study Group (IRSG) protocols III and IV, 1984-1997: a report from the Children's Oncology Group, R. Beverly Raney, James R. Anderson, Kenneth L.B. Brown, Winston W. Huh, Harold M. Maurer, William H. Meyer, David M. Parham, David A. Rodeberg, Suzanne L. Wolden, Sarah S. Donaldson, and Soft-Tissue Sarcoma Committee of the Children's Oncology Group Arcadia California USA

Link

Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy, Joseph A. Sparano, Etta D. Pisano, Julia R. White, Kelly K. Hunt, Eleftherios P. Mamounas, Edith A. Perez, Gabriel N. Hortobagyi, Julie R. Gralow, and Robert L. Comis

Link

Results of a multi-institutional benchmark test for cranial CT/MR image registration, Kenneth Ulin, Joel M. Cherlow, and Marcia Urie

Publications from 2009

Link

Developing a multi-institutional PACS archive and designing processes to manage the shift from a film to a digital-based archive, Nicole K. Laprise, Richard Hanusik, Thomas J. FitzGerald, Nancy Rosen, and Keith S. White

Link

Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancer, Thomas E. Stinchcombe, Lydia Hodgson, James E. Herndon 2nd, Michael J. Kelley, M. Giulia Cicchetti, Nithya Ramnath, Harvey B. Niell, James N. Atkins, Wallace Akerley, Mark R. Green, and Everett E. Vokes

Link

Improving cancer outcomes through international collaboration in academic cancer treatment trials, Edward L. Trimble and Thomas J. FitzGerald

Publications from 2007

Link

Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B, Everett E. Vokes, James E. Herndon 2nd, Michael J. Kelley, Maria Giulia Cicchetti, Nithya Ramnath, Harvey Neill, James N. Atkins, Dorothy M. Watson, Wallace Akerley, and Mark R. Green